InsidersTradesSigma
Total declarations
Company
▲ Purchases (2 ops.)
▼ Sales (0 ops.)
Insider track record
Board DirectorDisclosed buys
2
Disclosed sells
0
T+90 hit rate
0%
T+90 mean return
-19.7%
Across 2 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Discover the complete record of transactions filed by BARBERICH TIMOTHY J, Director. Insider active across 1 company, notably TScan Therapeutics, Inc.. In total, 4 reports have been logged. Breakdown: 2 buys · 0 sell. Total volume traded: €222k. History available since 2 June 2023. The latest transaction was filed on 18 December 2023 (Acquisition). Regulator: SEC (Form 4). All data is free.
Declarations4 total
28,830 shares@ US$4.886658.3% of flowVoting Common StockSEC:0000950170-23-072291:0
Ideal exit: 13 Sept 2024 (T+270)
37,880 shares@ US$2.628441.7% of flowVoting Common StockSEC:0000899243-23-014618:0
Ideal exit: 27 Feb 2024 (T+270)
33,259 sharesVoting Common StockSEC:0000899243-21-029440
33,259 sharesVoting Common StockSEC:0000899243-21-029440:0
4 of 4 declarations
About BARBERICH TIMOTHY J
Timothy J. Barberich serves as a Director at TScan Therapeutics, Inc. As a board member, he contributes to the strategic direction of the company and oversees its activities. Timothy brings extensive experience in the biotechnology sector, enabling him to assess growth and innovation opportunities. His role is crucial in ensuring compliance and transparency in the company's governance.
